Changwei Dou

Zero to Three — United States

Medicine · Health Sciences

27h-index2.9kcitations79works1.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cholangiocarcinoma and Gallbladder Cancer Studies(18), Cancer-related molecular mechanisms research(14), RNA modifications and cancer(12), MicroRNA in disease regulation(10), Gallbladder and Bile Duct Disorders(10)

Publications78 total

Retraction Note: Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression
BMC Cancer·2025Open Access
2138P First-in-human study of BA1301, a novel CLDN18.2-targeting antibody-drug conjugate in advanced solid tumors
Annals of Oncology·2025
Dual enzyme-driven redox homeostasis disruption with ultrasmall Pt-decorated MoS2 for combined ferroptosis therapy of hepatocellular carcinoma
Materials Today Bio·2025· 1 citedOpen Access
Tumor microenvironment responsive polymer nano-immunomodulators for precise immunotherapy of hepatocellular carcinoma
Chemical Engineering Journal·2025
Retraction: Methylation-mediated repression of microRNA-129-2 suppresses cell aggressiveness by inhibiting high mobility group box 1 in human hepatocellular carcinoma
Oncotarget·2025Open Access
Retraction: Ftx non coding RNA-derived miR-545 promotes cell proliferation by targeting RIG-I in hepatocellular carcinoma
Oncotarget·2025Open Access
<scp>LYRM2</scp> Promotes the Growth and Metastasis of Hepatocellular Carcinoma via Enhancing <scp>HIF</scp>‐1α‐Dependent Glucose Metabolic Reprogramming
Journal of Cellular and Molecular Medicine·2024· 2 citedOpen Access
Evolution from laparoscopic to robotic radical resection for gallbladder cancer: a propensity score-matched comparative study
Surgical Endoscopy·2024· 1 cited
Evaluation of the outcomes of biliary-enteric reconstruction in robotic radical resection of hilar cholangiocarcinoma: a single-center propensity score matching analysis
Scientific Reports·2024· 10 citedOpen Access
Evaluation of the outcomes of biliary-enteric reconstruction in robotic radical resection of hilar cholangiocarcinoma: a single-centre propensity score matching analysis
Research Square (Research Square)·2024Open Access
[Corrigendum] MicroRNA‑92a contributes to tumor growth of human hepatocellular carcinoma by targeting FBXW7
Oncology Reports·2023Open Access
Retraction Note: BCORL1 is an independent prognostic marker and contributes to cell migration and invasion in human hepatocellular carcinoma
BMC Cancer·2023· 1 citedOpen Access
Standardized lymph node dissection for gallbladder cancer under laparoscopy: en-bloc resection technique
Langenbeck s Archives of Surgery·2023· 9 cited
Laparoscopic versus open surgery for perihilar cholangiocarcinoma: a multicenter propensity score analysis of short- term outcomes
BMC Cancer·2023· 11 citedOpen Access
ASO Visual Abstract: The Long-Term Outcome of Laparoscopic Resection for Perihilar Cholangiocarcinoma Compared with the Open Approach: A Real-world, Multicentric Analysis
Annals of Surgical Oncology·2023
Hypoxia-induced up-regulation of VASP promotes invasiveness and metastasis of hepatocellular carcinoma: Erratum
Theranostics·2023Open Access
[Corrigendum] BCL‑3 promotes the tumor growth of hepatocellular carcinoma by regulating cell proliferation and the cell cycle through cyclin D1
Oncology Reports·2022Open Access
Corrigendum to “Oviductus ranae protein hydrolysate (ORPH) inhibits the growth, metastasis and glycolysis of HCC by targeting miR-491-5p/PKM2 axis” [Biomed. Pharmacother. 107 (2018) 1692–1704]
Biomedicine & Pharmacotherapy·2022· 1 citedOpen Access
The Long-Term Outcome of Laparoscopic Resection for Perihilar Cholangiocarcinoma Compared with the Open Approach: A Real-World Multicentric Analysis
Annals of Surgical Oncology·2022· 19 citedOpen Access
Retraction Note: MicroRNA-1468 promotes tumor progression by activating PPAR-γ-mediated AKT signaling in human hepatocellular carcinoma
Journal of Experimental & Clinical Cancer Research·2022Open Access
page 1 of 4Next →

Frequent Co-authors

Kangsheng Tu(28), Zhikui Liu(23), Yufeng Wang(16), Yuli Jia(13), Qingguang Liu(12), Wei Yang(11), Xin Zheng(11), Bowen Yao(10), Meng Xu(10), Qing Li(9), Yingmin Yao(9), Cheng-Wu Zhang(8), Qiuran Xu(7), Qingguang Liu(7), Qing Li(6), Jie Liu(5), Liang Wang(4), Lifeng Ding(4), Hongyong Zhang(4), Yuqun Zeng(4)